Expressional change in calcitonin gene-related peptide, receptor activity modifying protein 1 (RAMP1) and bradykinin 1 receptor after experimental inflammation in rat trigeminal ganglia

Current Neurobiology

Volumn 1, Issue 1, 2010, Pages 82-88

  Kristiansen, Kim A ^a   Edvinsson, Lars ^a  

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Calcitonin gene related peptide; Cytokines; Inflammation; Migraine; Trigeminal ganglia

Indexed keywords

BRADYKININ B1 RECEPTOR; CALCITONIN GENE RELATED PEPTIDE; RECEPTOR ACTIVITY MODIFYING PROTEIN 1;

ANIMAL TISSUE; ARTICLE; CELL GRANULE; CELL NUCLEUS; CELL VACUOLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; INFLAMMATION; MALE; NERVE CELL; NONHUMAN; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; TISSUE CULTURE CELL; TRIGEMINUS GANGLION;

EID: 78650514908     PISSN: 09759042     EISSN: 09761705     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Edvinsson L: Blockade of CGRP receptors in the intracranial vasculature: a new target in the treatment of headache. Cephalalgia 2004; 24:611-622.
2. Edvinsson L: CGRP-receptor antagonism in migraine treatment. Lancet 2008;372:2089-2090.
3. Martinez F, Castillo J, Rodriguez JR, Leira R, Noya M: Neuroexcitatory amino acid levels in plasma and cerebrospinal fluid during migraine attacks. Cephalalgia 1993;13:89-93.
4. Ferrari MD, Odink J, Bos KD, Malessy MJ, Bruyn GW: Neuroexcitatory plasma amino acids are elevated in migraine. Neurology 1990;40:1582-1586.
5. Cananzi AR, D'Andrea G, Perini F, Zamberlan F, Welch KM: Platelet and plasma levels of glutamate and glutamine in migraine with and without aura. Cephalalgia 1995;15:132-135.
6. Liu Y, Broman J, Edvinsson L: Central projections of sensory innervation of the rat superior sagittal sinus. Neuroscience 2004;129:431-437.
7. Liu Y, Broman J, Edvinsson L: Central projections of the sensory innervation of the rat middle meningeal artery. Brain Res 2008;1208:103-110.
8. Uddman R, Tajti J, Hou M, Sundler F, Edvinsson L: Neuropeptide expression in the human trigeminal nucleus caudalis and in the cervical spinal cord C1 and C2. Cephalalgia 2002;22:112-116.
9. Tajti J, Uddman R, Moller S, Sundler F, Edvinsson L: Messenger molecules and receptor mRNA in the human trigeminal ganglion. J Auton Nerv Syst 1999;76:176-183.
10. Christensen ML, Eades SK, Fuseau E, Kempsford RD, Phelps SJ, Hak LJ: Pharmacokinetics of naratriptan in adolescent subjects with a history of migraine. J Clin Pharmacol 2001;41:170-175.
11. Liu Y, Broman J, Zhang M, Edvinsson L: Brainstem and thalamic projections from a craniovascular sensory nervous centre in the rostral cervical spinal dorsal horn of rats. Cephalalgia 2009;29:935-948.
12. Ma QP: Co-localization of 5-HT(1B/1D/1F) receptors and glutamate in trigeminal ganglia in rats. Neuroreport 2001;12:1589-1591.
13. Hou M, Kanje M, Longmore J, Tajti J, Uddman R, Edvinsson L: 5-HT(1B) and 5-HT(1D) receptors in the human trigeminal ganglion: co-localization with calcitonin gene-related peptide, substance P and nitric oxide synthase. Brain Res 2001;909:112-120.
14. Xiao Y, Richter JA, Hurley JH: Release of glutamate and CGRP from trigeminal ganglion neurons: Role of calcium channels and 5-HT1 receptor signaling. Mol Pain 2008;4:12.
15. Goadsby PJ, Edvinsson L, Ekman R: Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 1990;28:183-187.
16. Moskowitz MA: Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine. Trends Pharmacol Sci 1992;13:307-311.
17. Rothwell NJ, Hopkins SJ: Cytokines and the nervous system II: Actions and mechanisms of action. Trends Neurosci 1995;18:130-136.
18. Kocer A, Memisogullari R, Domac FM, Ilhan A, Kocer E, Okuyucu S, Ozdemir B, Yuksel H: IL-6 levels in migraine patients receiving topiramate. Pain Pract 2009;9:375-379.
19. Capuano A, De CA, Lisi L, Tringali G, Navarra P, Dello RC: Proinflammatory-activated trigeminal satellite cells promote neuronal sensitization: relevance for migraine pathology. Mol Pain 2009;5:43.
20. Damodaram S, Thalakoti S, Freeman SE, Garrett FG, Durham PL: Tonabersat inhibits trigeminal ganglion neuronal-satellite glial cell signaling. Headache 2009;49:5-20.
21. Garrett FG, Durham PL: Differential expression of connexins in trigeminal ganglion neurons and satellite glial cells in response to chronic or acute joint inflammation. Neuron Glia Biol 2009;1-12.
22. Thalakoti S, Patil VV, Damodaram S, Vause CV, Langford LE, Freeman SE, Durham PL: Neuron-glia signaling in trigeminal ganglion: implications for migraine pathology. Headache 2007;47:1008-1023.
23. Calixto JB, Medeiros R, Fernandes ES, Ferreira J, Cabrini DA, Campos MM: Kinin B1 receptors: key G-protein-coupled receptors and their role in inflammatory and painful processes. Br J Pharmacol 2004;143:803-818.
24. Calixto JB, Cabrini DA, Ferreira J, Campos MM: Kinins in pain and inflammation. Pain 2000;87:1-5.
25. Talbot S, Theberge-Turmel P, Liazoghli D, Senecal J, Gaudreau P, Couture R: Cellular localization of kinin B1 receptor in the spinal cord of streptozotocin-diabetic rats with a fluorescent [Nalpha-Bodipy]-des-Arg9-bradykinin. J Neuroinflammation 2009;6:11.
26. Cunha FQ, Poole S, Lorenzetti BB, Ferreira SH: The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia. Br J Pharmacol 1992;107:660-664.
27. Davis AJ, Perkins MN: The involvement of bradykinin B1 and B2 receptor mechanisms in cytokine-induced mechanical hyperalgesia in the rat. Br J Pharmacol 1994;113:63-68.
28. Waeber C, Moskowitz MA: Migraine as an inflammatory disorder. Neurology 2005;64:S9-15.
29. Rashid MH, Inoue M, Matsumoto M, Ueda H: Switching of bradykinin-mediated nociception following partial sciatic nerve injury in mice. J Pharmacol Exp Ther 2004;308:1158-1164.
30. Lennerz JK, Ruhle V, Ceppa EP, Neuhuber WL, Bunnett NW, Grady EF, Messlinger K: Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: differences between peripheral and central CGRP receptor distribution. J Comp Neurol 2008; 507:1277-1299.